SAHPRA Registration Services End - to - End Regulatory Consulting for Medical Device & IVD Approval in South Africa Operon Strategist | South African Regulatory Entry Regulatory Gateway to Africa South Africa represents one of the largest and most sophisticated medical device markets on the African continent. Market entry requires strict adherence to statutory frameworks enforced by the South African Health Products Regulatory Authority (SAHPRA). ElevatePlus Execution Strategy Operon ElevatePlus delivers an execution - ready consulting pathway. We assist global manufacturers, importers, and distributors from initial device classification to local representation, dossier drafting, and final establishment licensing. South Africa Market Access The South African Health Products Regulatory Authority (SAHPRA) regulates all health products under the Medicines and Related Substances Act, 1965 (Act 101 of 1965) Mandatory establishment licensing for manufacturers, importers, and distributors. Risk - based device classification aligned with IMDRF principles. Strict verification of Quality Management Systems (ISO 13485 compliance). Involvement of an Authorized Representative (AR) for all foreign legal entities. SAHPRA Regulatory Authority Risk Class Risk Level Example Products Regulatory Pathway Class A Low Risk Bandages, tongue depressors, manual wheelchairs Establishment License listing (Exempt if non - sterile/non - measuring) Class B Low to Moderate Hypodermic needles, suction equipment Establishment License + Technical Dossier Review Class C Moderate to High Ventilators, dialysis machines, blood bags Full Technical Dossier + Foreign Regulator Reliance Verification Class D High Risk Pacemakers, HIV/TB IVD test kits, coronary stents Priority Technical Review + Full SAHPRA Pre - market Approval Device Risk Classification Strategy & Mapping Accurate classification mapping according to SAHPRA guidelines (Class A, B, C, D) and tailored roadmap development. Authorized Rep (AR) Official local nomination support and regulatory liaison between foreign manufacturers and SAHPRA officers. Dossier Preparation Technical file compilation, Essential Principles mapping, and leveraging reference approvals (FDA/CE). ElevatePlus Service Portfolio Intended Use & Risk Profiling Regulatory success begins with establishing the exact intended purpose and GMDN/UMDNS categorization. Misclassification leads to severe delays or unnecessary submission overhead. Market Entry Optimization We evaluate your existing international approval portfolio (US FDA, CE Mark, TGA, Health Canada) to leverage SAHPRA's reliance pathways, minimizing re - evaluation timelines and costs. Pathway Mapping & Strategy Mandatory Local Presence Foreign manufacturers without a physical presence in South Africa must formally appoint an Authorized Representative (AR) who is a natural person or registered entity residing in South Africa. The AR acts as the official legal liaison to SAHPRA, oversees license applications, maintains technical records, and handles vigilance and post - market safety communications. Authorized Representative Role Essential Principles Conformity: Demonstrating rigorous safety, design, and performance compliance in line with SAHPRA requirements. Risk Management Documentation: Detailed risk analysis files developed according to ISO 14971 frameworks. Clinical Data Evaluation: Appraisal of clinical evidence, performance studies, and literature reviews tailored to Class C and D devices. Labelling & IFU Adaptation: Customizing primary/secondary packaging labels and Instructions for Use (IFU) to meet South African local regulations. Technical Dossier Compliance SAHPRA enforces strict Quality Management System guidelines for establishment license holders and manufacturers. Phase 1: Implementation Establishment of ISO 13485 core quality procedures and gap identification. Phase 2: License Renewal Mandatory proof of ISO 13485 certification during establishment license renewals. Phase 3: Full Scope Compulsory ISO 13485 evidence required for all license updates and amendments. Phase 4: New Filings Mandatory ISO 13485 accredited certification for all new establishment applications. QMS & ISO 13485 Mandate Manufacturer License Required for entities manufacturing, packaging, relabeling, servicing, or assembling medical devices in South Africa. Import & Distribute Mandatory establishment license enabling legal importation and wholesale distribution across South Africa. Wholesale License Covers storage, logistics, transportation, and delivery compliance in accordance with Good Distribution Practices (GDP). SAHPRA Establishment Licensing SAHPRA heavily utilizes reliance pathways based on existing approvals from recognized jurisdictions to expedite technical eva lua tion and review times. International Reliance Routes Step 1: Classification Device assessment, GMDN coding, and reliance pathway determination. Step 2: AR Nomination Appointment of local AR and preparation of establishment license. Step 3: Dossier Submission Filing of complete technical dossier and payment of official fees. Step 4: Review & License Addressing RFIs, securing registration certificate, and market release. SAHPRA Registration Lifecycle Local Vigilance & Incident Reporting License holders and Authorized Representatives must establish robust vigilance mechanisms to capture and report adverse events, malfunctions, or patient harm to SAHPRA within mandated timelines. Recalls & Field Safety Actions Operon Strategist assists in creating execution - ready Field Safety Corrective Action (FSCA) protocols, managing product recalls, and maintaining compliance logbooks required during SAHPRA audits. Post - Market Surveillance Global Exposure Proven track record across South Africa, US, EU, GCC, and APAC markets with structured multi - country submission strategies. Dual MD & IVD Expertise Dedicated technical teams specialized in complex medical devices and high - risk In - Vitro Diagnostics (IVDs). 1965 Act Master Plan In - depth mastery of the Medicines and Related Substances Act, preventing compliance gaps and avoidable rejections. What Sets Operon Apart 100% Compliant Market Entry Zero - Gap Regulatory Execution By conducting rigorous preliminary audits and gap analysis before dossier submission, Operon ElevatePlus eliminates classification errors and administrative delays. Our end - to - end management covers establishment licensing, AR coordination, QMS alignment, and ongoing lifecycle extensions for full peace of mind. Operon Registration Advantage Common Pitfalls to Avoid Frequent causes for submission rejection include improper GMDN mapping, missing ISO 13485 scopes, invalid reliance certificate authentications, and lack of localized IFU labeling. Operon Risk Mitigation We deploy rigorous internal pre - submission checklists, direct communication with SAHPRA reviewers, and proactive response management for Requests for Further Information (RFIs). Preventing Regulatory Delays South Africa relies heavily on medical device imports (>90%). Timely SAHPRA licensing opens immediate procurement access for bot h public tenders and private healthcare sector contracts. SA Medical Device Market Continuous growth in successful establishment licenses and technical dossier approvals managed by Operon Strategist across gl oba l client jurisdictions. Operon Regulatory Track Record Design History File (DHF): Complete documentation and design control support from concept to commercialization. CE & UKCA Marking: EU MDR 2017/745 & IVDR 2017/746 technical documentation and Notified Body support. US FDA Clearances: 510(k) submissions, QMSR implementation, and FDA Establishment Registration. SFDA & Regional Registrations: Saudi Arabia SFDA approval, BIS Certification, and Regulatory Due Diligence. Comprehensive Compliance Services 1. Initial Consult In - depth device review, portfolio evaluation, and regulatory scope definition with regulatory experts. 2. Audit & Gap Assessment Thorough evaluation of technical documentation, QMS status, and local representation requirements. 3. Filing & Approval Seamless execution, official SAHPRA dossier submission, reviewer management, and final license issuance. Client Engagement Roadmap